Gestodene
From Wikipedia, the free encyclopedia
|
Gestodene
|
|
| Systematic (IUPAC) name | |
| (8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | G03 |
| PubChem | |
| Chemical data | |
| Formula | C21H26O2 |
| Mol. mass | 310.430 g/mol |
| Pharmacokinetic data | |
| Bioavailability | in vitro 99% using 3H=R5020 / in vivo similar to progesterone |
| Metabolism | ? |
| Half life | 16 to 18 hrs. |
| Excretion | urinary tract mainly |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | oral administration |
Gestodene is a progestogen hormonal contraceptive. Products containing gestoden include Meliane which contains 20 mcg of ethinylestradiol and 75 mcg of gestodene and is used as a contraceptive.

